AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Year-over-year revenue growth rate
3Y CAGR
-28.0%/yr
vs +53.9%/yr prior
Acceleration
-81.9pp
Decelerating
Percentile
P59
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 4.35% |
| Q3 2025 | 5.31% |
| Q2 2025 | -6.13% |
| Q1 2025 | 5.06% |
| Q4 2024 | 2.34% |
| Q3 2024 | 3.03% |
| Q2 2024 | -0.17% |
| Q1 2024 | 3.11% |
| Q4 2023 | 1.83% |
| Q3 2023 | 5.38% |
| Q2 2023 | 5.83% |
| Q1 2023 | 1.03% |
| Q4 2022 | 11.63% |
| Q3 2022 | -7.96% |
| Q2 2022 | 7.34% |
| Q1 2022 | -3.21% |
| Q4 2021 | 1.01% |
| Q3 2021 | 4.21% |
| Q2 2021 | -4.99% |
| Q1 2021 | -5.71% |
| Q4 2020 | -1.83% |
| Q3 2020 | 9.43% |
| Q2 2020 | -3.79% |
| Q1 2020 | 4.47% |
| Q4 2019 | 5.26% |
| Q3 2019 | 2.86% |
| Q2 2019 | 4.53% |
| Q1 2019 | -1.41% |
| Q4 2018 | 11.19% |
| Q3 2018 | 11.79% |
| Q2 2018 | 7.49% |
| Q1 2018 | -9.35% |
| Q4 2017 | -1.90% |
| Q3 2017 | 20.14% |
| Q2 2017 | 6.19% |
| Q1 2017 | -10.78% |
| Q4 2016 | 3.46% |
| Q3 2016 | 1.33% |
| Q2 2016 | 1.61% |
| Q1 2016 | 4.90% |